| Monday 30th April 2018 | ||
| 10.00 - 13.00 | Executive Committee Meeting Invitation only | |
| 11.00 - 17.30 | Registration / Speaker Preview Open | |
| 14.30 - 17.30 | Trainers Seminar Free to attend, but places MUST be pre-booked (only free of charge if attending full conference) | |
| 17.30 - 19.00 | Welcome Reception | |
| Tuesday 1st May 2018 | ||
| 09.00 - 09.10 | Welcome Pierre Martin-Hirsch, Chair Local Organising Committee | |
| 09.10 - 10.10 | Plenary Session 1 Chairs: Pierre Martin Hirsch and Theresa Freeman Wang Natural History of HPV Infection and Triggers of Cervical Carcinogenesis: How has the Evidence evolved Dr Barbara Moscicki ASCCP, USA Screening in the Over 60's: Is it Effective? Professor Peter Sasieni, Wolfson Institute, UK | |
| 10.10 - 10.20 | Panel Discussion | |
| 10.20 - 10.50 | Proffered Papers: Session 1 | |
| 10.50 - 11.20 | Tea/Coffee/Exhibition/Poster Viewing | |
| 11.20 - 12.20 | Plenary Session 2 Current Evidence for the Management of VIN DR Amanda Tristram, Wellington, New Zealand Current Evidence for Management AIN Professor Andrew Renehan, University of Manchester, UK | |
| 09.00 - 09.10 | BSCCP AGM | |
| 13.00 - 14.00 | Lunch/Exhibition/Poster Viewing | |
| 14.00 - 15.20 | Plenary Session 3 | |
| 14.05 - 14.10 | Presentation of Founders Medal: Patrick Walker, UK Presented to: Walter Prendiville, Coombe Women’s Hospital, Tallaght Hospital and Royal College of Surgeons in Ireland | |
| 14.05 - 14.30 | Innovation, Evolution, Vaccination: What Will Work in LMICs? Professor Walter Prendiville, Coombe Women’s Hospital, Tallaght Hospital and Royal College of Surgeons in Ireland | |
| 14.30 - 15.15 | Proffered Paper: Session 2 | |
| 15.15 - 15.45 | Tea/Coffee/Exhibition/Poster Viewing | |
| 15.45 - 17.00 | Plenary Session 4 Quality Assurance In Cervical Screening Organising with North QA Team Ms Philippa Pearmain, Cancer Screening Quality Assurance, UK Data Collection in Colposcopy Practice Ms Philippa Pearmain, Cancer Screening Quality Assurance, UK 3 Question and Answers Presentations: Scotland, Wales, Ireland Challenges for Cervical Screening in the Next Decade Ruth Stubbs, Northwest Cervical Screening Quality Assurance Reference Centre, Liverpool, UK | |
| 17.00 - 18.00 | TBC | |
| Wednesday 2nd May 2018 | ||
| 09.00 -10.00 | Plenary Session 5 Prophylactic and Therapeutic HPV Vaccination Dr Warner Huh, University of Alabama, USA Impact of HPV Vaccination in Australia Professor Karen Canfell, Cancer Council, Australia | |
| 10.00 - 10.10 | Panel Discussion | |
| 10.10 - 10.40 | Proffered Papers: Session 3 | |
| 10.40 - 11.10 | Tea/Coffee/Exhibition/Poster Viewing | |
| 11.10 - 12.10 | Plenary Session 6 Pregnancy and Oncological Outcomes after Fertility-Sparing Surgery for Cervical Cancer Dr Denis Querleu, ESGO, France Pregnancy and Oncological Outcomes after Fertility-Sparing Surgery for Cervical Pre-Cancer Dr Maria Kyrgiou, Imperial College London, UK | |
| 12.10 - 13.00 | Patient Experience Jo’s Trust TBC | |
| 13.00 - 14.00 | Lunch/Exhibition/Poster Viewing | |
| 14.00 - 15.10 | Plenary Session 7 Current Evidence from Primary HPV Screening Pilot Study and Future Implementation Professor Henry Kitchener, The University of Manchester, UK Screening after Vaccination Professor Karen Canfell, Cancer Council, Australia Discussion | |
| 15.10 - 16.00 | Proffered Papers: Session 4 | |
| 16.00 - 16.30 | Tea/Coffee/Exhibition/Poster Viewing | |
| 16.30 - 17.30 | Plenary Session 8 Urine and Self Sampling HPV Testing: Current Evidence Dr Emma Crosbie, University of Manchester, UK NICE Review on Adjuncts to Aid Colposcopy Ms Theresa Freeman-Wang, Whittington Health, UK Proposed RCT in Topical Lopinavir Pierre Martin-Hirsch, Chair Local Organising Committee | |
| 17.30 - 17.40 | Presentations and Closing Remarks | |
